Handan Özek Erkuran, M.D.
13.03.2019

CURRICULUM VITAE

HANDAN ÖZEK ERKURAN, MD

1.    PERSONAL INFORMATION

Date of Birth/Hometown:    1982/ Ankara
Sex:                                        Female
Marital Status:                      Married
Native Language:                 Turkish
Foreign Language:               English (advanced), German (intermediate)

2.      CURRENT PROFESSIONAL POSITION

MD, Consultant Child and Adolescent Psychiatrist (2013-)

University of Health Sciences, Izmir Dr. Behcet Uz Children’s Research and Training Hospital, Child and Adolescent Psychiatry Department

3.      EDUCATION/POSTGRADUATE TRAINING

Ankara University Faculty of Medicine, 1999-2006

Dokuz Eylül University Faculty of Medicine ; Residency Training in  Child and Adolescent Psychiatry Department, 2007- 2012

4.      PREVIOUS PROFESSIONAL WORK EXPERIENCE

·         Dokuz Eylül University Faculty of Medicine ; Residency Training in  Child and Adolescent Psychiatry Department (2007- 2012)

·         Balıkesir Ataturk State Hospital, Child and Adolescent Psychiatry Unit (2012-2013)

·         Izmir Buca Gyneacology, Obstetrics and Pediatrics Hospital, Child and Adolescent Psychiatry Unit (2013)

·         Turkish Ministry of Health  Kayseri Research and Training Hospital, Child and Adolescent Psychiatry Unit (2014)

·         University of Health Sciences, Izmir Dr. Behcet Uz Children’s Research and Training Hospital, Child and Adolescent Psychiatry Department (2013-)

5.      TRAINING/COURSES

·         Tavistock Clinic M-14 Child and Adolescent Psychoanalytic Training and Infamt Observation Module for Child Psychiatrists, 2007-2018

·         Psychodinamic Concepts in Practice, Tavistock Clinic Workshop, March 2008

·         Kiddie and Young Adult Schedule for Affective Disorders and Schizophrenia – Present State and Lifetime (K-SADS P-L) Turkish Version Course, Hacettepe University Faculty of Medicine Department of Child Psychiatry, 2008

·         Emotional Availaibility Training Workshop, Ankara University Faculty of Medicine Department of Child Psychiatry , Ankara, April 2011

·         Cognitive and Behavioral Therapy Training for Children and Adolescents, Theoretical and Practice Modules completed. Therapist/Trainer: Maria Ceu Salvador. 2016-2018, Istanbul/Turkey

6.      PUBLICATIONS:

A.    International peer-reviewed publications:

1.      Pekcanlar Akay A, Hiz Kurul S, Özek H, Cengizhan S, Emiroğlu N, Ellidokuz H. Maternal Reactions to a child with epilepsy: Depression, anxiety, parental attitudes and family functions. Epilepsy Research 2011; 95(3): 213-20.

2.      Sargin E, Akay A, Resmi H, Cengizhan S, Özek H, Ellidokuz H, Miral S, Orcin E. Evaluation of Serum Brain- Derived Neurotrophic Factor Levels in Children with Attention Deficit Hyperactivity Disorder: Preliminary Data. Archives of Neuropsychiatry 2012; 49(2): 96-101.

3.      Dursun OB, Guvenir T, Aras S, Ergin C, Mutlu C, Baydur A, Ozbek A, Özek H, Alsen S, İscanli L, Karaman BI, Goodman R. A new Diagnostic Approach for Turkish speaking Populations: DAWBA Turkish version. Epidemiology and Psychiatric Sciences 2012; 22(3): 1-8.

4.      Alsen S, Resmi H, Erkuran HÖ, Tufan AE, Bulbul M, Akay A. Plasma norepinephrine and dopamine levels in prepubertal male children with Attention Deficit Hyperactivity Disorder do not change with 8 weeks of methylphenidate Treatment. Bulletin of Clinical Psychopharmacology 2015; 25(3):1.

5.      Akay AP, Kaya GC, Baykara B, Demir Y, Erkuran HÖ, Alsen S, Eren MS, Emiroglu NI, Ertay T, Ozturk Y, Miral S, Durak H, Tufan AE. Atomoxetine Treatment may decrease striatal dopaminergic transporter availability after 8 .weeks: Pilot SPECT report of three cases. Neuropsychiatric Disease and Treatment 2015 Nov 19;11:2909-2912.

6.      Akinci G, Oztura I, Hiz S, Akdogan O, Karaarslan D, Erkuran HÖ,  Akay A. Sleep Structure in Children With Attention-Deficit/Hyperactivity Disorder. Journal of Child Neurology 2015; 30(11): 1520–1525. 

7.      Sapmaz ŞY, Sargın E, Ergin C, Erkuran HÖ, Öztürk M, Aydemir Ö. The Reliability and Validity of Turkish Version of DSM-5 Level 2 Substance Use Disorder Scale. Journal of Dependence 2016;17(3): 116-122.

8.      Erkuran HÖ, Cakaloz B, Onen O, Kutlu A. Suicide attempt with high dose long acting methylphenidate ingestion: a case presentation. Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology. 2016 Sep 1;26(3):316-8.

9.      Yalın Sapmaz Ş, Ergin D, Şen Celasin N, Erkuran HÖ, Karaarslan D, Öztekin S, Uzel Tanrıverdi B, Köroğlu E, Aydemir Ö. Validity and reliability of the Turkish version of the DSM-5 Dissociative Symptoms Severity Scale–Child Form. Journal of Trauma & Dissociation. 2017 Aug 8;18(4):624-34.

10.  Onen O, Erkuran HÖ. Topiramate in the Adjunctıve Treatment of Tourette Syndrome: A Case Report. Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology. 2016 Dec 1;26(4):426-8.

11.  Sapmaz SY, Erkuran HÖ, Ergin D, Ozturk M, Sen Celasin N, Karaarslan D, Koroglu E, Aydemir O. The reliability and validity of the Turkish Version of the DSM-5 Panic Disorder Severity Scale-Child Form. JOURNAL OF MOOD DISORDERS. 2017 Jan 1;7(2):110-5.

12.  Önen Ö, Kutlu A, Erkuran HÖ. Treating an Adolescent with Long QT Syndrome for Bipolar Disorder: A Case Presentation. Psychopharmacology bulletin. 2017 Jan 26;47(1):33.

13.  Kutlu A, Erkuran HÖ. Okul öncesi yas grubunda bipolar bozukluk: Üç olgu ve izleme süreçleri/Preschool bipolar disorder: three cases and their follow-up. Anatolian Journal of Psychiatry 2017 Feb 1;18:15.

14.  Sapmaz SY, Erkuran HÖ, Ergin D, Celasin NS, Karaarslan D, Ozturk M, Koroglu E, Aydemir O. Validity and Reliability of the Turkish Version of DSM-5" Severity of Acute Stress Symptoms--Child Age 11-17" Form. Dusunen Adam: Journal of Psychiatry & Neurological Sciences. 2017 Mar 1;30(1).

15.  Yalin Sapmaz S, Erkuran HÖ, Aydemir O. Validity and reliability of the Turkish version of DSM-5 Level 2 Repetitive Thoughts and Behaviors Scale-Child Form. ANADOLU PSIKIYATRI DERGISI-ANATOLIAN JOURNAL OF PSYCHIATRY. 2017 Apr 1;18(2):107-13.

16.  Yalin Sapmaz S, Erkuran HÖ, Kavurma C, Ozturk M, Uzel Tanriverdi B, Koroglu E, Aydemir O. Validity and reliability of DSM-5 Level 1 Cross-Cutting Symptom Scale Turkish Version (Child Form for 11-17 Years and Parent Form for 6-17 Years). ANADOLU PSIKIYATRI DERGISI-ANATOLIAN JOURNAL OF PSYCHIATRY. 2017 Apr 1;18(2):99-106.

17.  Yalin Sapmaz S, Yalin N, Erkuran HÖ, Oztekin S, Uzel Tanriverdi B, Koroglu E, Aydemir O. Validity and reliability of the Turkish version of DSM-5 Depression Severity Scale-Child Form. ANADOLU PSIKIYATRI DERGISI-ANATOLIAN JOURNAL OF PSYCHIATRY. 2017 Jun 1;18(3):237-42.

18.  Sapmaz ŞY, Ergin D, Erkuran HÖ, Celasin NŞ, Öztürk M, Karaarslan D, Köroğlu E, Aydemir Ö. Validity and Reliability of the Turkish Version of the DSM-5 Posttraumatic Stress Symptom Severity Scale-Child Form. Archives of Neuropsychiatry. 2017 Sep;54(3):205.

19.  Sapmaz SY, Erkuran HÖ, Ergin D, Ozturk M, Celasin NS, Karaarslan D, Koroglu E, Aydemir O. Validity and reliability of the Turkish version of the DSM-5 “Severity Measure for Agoraphobia—Child Age 11–17”. DUSUNEN ADAM-JOURNAL OF PSYCHIATRY AND NEUROLOGICAL SCIENCES. 2017 Sep 1;30(3):217-23.

20.  SAPMAZ ŞY, ERKURAN HÖ, Yalin N, ÖNEN Ö, ÖZTEKİN S, Kavurma C, KÖROĞLU E, AYDEMİR Ö. Validity and Reliability of the Turkish Version for DSM-5 Level 2 Anger Scale (Child Form for Children Aged 11–17 Years and Parent Form for Children Aged 6–17 Years). Archives of Neuropsychiatry. 2017 Dec;54(4):334.

21.  SAPMAZ ŞY, Ergin D, CELASİN NŞ, Karaarslan D, ÖZTÜRK M, ERKURAN HÖ, KÖROĞLU E, AYDEMİR Ö. Validity and Reliability of the Turkish version of DSM-5 Social Anxiety Disorder Severity Scale-Child Form. Archives of Neuropsychiatry. 2017 Dec;54(4):354.

22.  Yalın Sapmaz Ş, Erkuran HÖ, Öztürk M, Ergin D, Şen Celasin N, Karaarslan D, Köroğlu E, Aydemir Ö. Validity and reliability of the Turkish version of the DSM-5 Separation Anxiety Disorder Severity Scale–child form. Psychiatry and Clinical Psychopharmacology. 2017 Dec 12:1-7.

23.  Erkuran HÖ, Aydin Asik E, Yalin Sapmaz S. Diagnostic and treatment process in a 12-year old adolescent with Kleine-Levin Syndrome: a case presentation. ANADOLU PSIKIYATRI DERGISI-ANATOLIAN JOURNAL OF PSYCHIATRY. 2018 Jan 1;19(1):95-8.

24.  Akay AP, Resmi H, Güney SA, Erkuran HÖ, Özyurt G, Sargin E, Topuzoglu A, Tufan AE. Serum brain-derived neurotrophic factor levels in treatment-naïve boys with attention-deficit/hyperactivity disorder treated with methylphenidate: an 8-week, observational pretest–posttest study. European child & adolescent psychiatry. 2018 Jan 1;27(1):127-35.

25.  Sapmaz ŞY, Erkuran HÖ, Karaarslan D, Öztürk M, Ülker GY, Demirgören BS, Köroğlu E, Aydemir Ö. Validity and Reliability of the Turkish Version of DSM-5 Level 2 Anxiety Scale (Child Form for 11-17 Years and Parent Form for 6-17 Years). Archives of Neuropsychiatry. 2018;55(2):152.

26.  SAPMAZ ŞY, ERKURAN HÖ, Ergin D, ÖZTÜRK M, CELASİN NŞ, Karaarslan D, AYDEMİR Ö. Validity and reliability of the Turkish version of the DSM-5 Generalized Anxiety Disorder Severity Scale for children aged 11-17 years. Turkish journal of medical sciences. 2018 Feb 23;48(1):74-9.

27.  Pekcanlar Akay A, Eresen Yazıcıoğlu Ç, Alşen Güney S, Erkuran HÖ, Kızıldağ S, Baykara B, Özyurt G, Yıldırımcan Kadıçeşme Ş, Miral S, İnal Emiroğlu N. Allele frequencies of dopamine D4 receptor gene (DRD4) and Catechol-O-methyltransferase (COMT) Val158Met polymorphism are associated with methylphenidate response in adolescents with attention deficit/hyperactivity disorder: a case control preliminary study. Psychiatry and Clinical Psychopharmacology. 2018 Apr 3;28(2):177-84.

28.  Önen Ö, Kundak S, Erkuran HÖ, Kutlu A, Çakaloz B. Quality of life, depression, and anxiety in Turkish children with vitiligo and their parents. Psychiatry and Clinical Psychopharmacology. 2018 Apr 5:1-0.

29.  Akay AP, Kaya GÇ, Kose S, Yazıcıoğlu ÇE, Erkuran HÖ, Güney SA, Oğuz K, Keskin D, Baykara B, Emiroğlu Nİ, Eren MŞ. Genetic imaging study with [Tc-99m] TRODAT-1 SPECT in adolescents with ADHD using OROS-methylphenidate. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 2018 Apr 20.

30.  Erkuran HÖ, Sapmaz ŞY, Herdem A, Öztürk M, Bilaç Ö, Önen Ö, Tanriverdi BU, Köroğlu E, Aydemir Ö. DSM-5 Level 2 Sleep Disorders Scale Validity and Reliability of Turkish Form (Form for Children Aged 11–17 Years and Parent Form for Children Aged 6–17 Years). Archives of Neuropsychiatry. 2018 Sep;55(3):256.

31.  Sapmaz SY, Erkuran HÖ, Ergin D, Ozturk M, Celasin NS, Karaarslan D, Koroglu E, Aydemir O. Validity and Reliability of the Turkish version of the Severity Measure for Specific Phobia-Child Form According to DSM-5. DUSUNEN ADAM-JOURNAL OF PSYCHIATRY AND NEUROLOGICAL SCIENCES. 2018 Dec 1;31(4):340-6.

32.  Yaylacı F, Erkuran HÖ, Çetin F, Kara H. Neurofeedback Training in the Treatment of Attention Deficit Hyperactivity Disorder. Psikiyatride Güncel Yaklaşımlar- Current Approaches in Psychiatry . 2019; 11 (3):1-1.

B.     National Peer-Reviewed publications:

1.      Erkuran HÖ, AKAY A. Prognosis and Predictive Factors for Mood Disorders in Children and Adolescents. Turkiye Klinikleri Journal of Child Psychiatry-Special Topics. 2016;2(1):96-100.

2.      Önen Ö, Gencer Ö, Erkuran HÖ, Ekin Lİ. Clinical Features, Coping Styles and Family Functioning in Relation To Psychiatric Disorders in Childhood Sexual Abuse. Literature Symposium 2016; 12.

3.      Sapmaz ŞY, Demirgören BS, Öztürk M, Bilaç Ö, Erkuran HÖ, Köroğlu E, Aydemir Ö. Validity and Reliability of the Turkish Version of DSM-5 Level 2 Inattention Scale (Parent Form for 6-17 Years). Turkish Journal of Child and Adolescent Mental Health 2016; 23(3): 227-233.

4.      Pilan BŞ, Bilaç Ö, Orhon Z, Erkuran HÖ. Medication Use in A Child and Adolescent Inpatient Unit of A Mental Health Hospital. Turkish Journal of Child and Adolescent Mental Health 2017; 24(3): 207- 218.

7.      International Presentations and Abstracts:

1.      Akay AP, Kaya GÇ, Baykara HB, Demir Y, Erkuran HÖ, Alşen S, Eren MŞ, Emiroğlu FN, Ertay T, Öztürk Y. “Tc-99m TRODAT Brain SPECT changes in patients with attention deficit hyperactivity disorder in pre- and post- atomoxetine treatment”. 25th ECNP Congress, Vienna, October 2012 (poster presentation)

2.      Akay AP, Kaya GÇ, Baykara HB, Demir Y, Erkuran HÖ, Alşen S, Eren MŞ, Emiroğlu FN, Ertay T, Öztürk Y. “Tc-99m TRODAT Brain SPECT changes in adolescents with attention deficit hyperactivity disorder after 2 months of methylphenidate therapy”. 25th ECNP Congress, Vienna, October 2012 (poster presentation)

3.      Akay AP, Resmi H, Erkuran HÖ, Özyurt G, Bülbül M, Demirgören BS, Beşenek AM. “Plasma Dopamine and Noradrenaline Levels in Children Diagnosed with Attention Deficit Hyperactivity Disorder: a Prospective Treatment Study”. 6th International Congress on Psychopharmacology and International Symposium on Child and Adolescent Psychopharmacology, Antalya, April 2014 (poster presentation)

4.      Akay AP, Erkuran HÖ, Resmi H, Ellidokuz H. “Plasma Dopamine and Noradrenaline Levels in Children Diagnosed with Attention Deficit Hyperactivity Disorder”. 6th International Congress on Psychopharmacology and International Symposium on Child and Adolescent Psychopharmacology, Antalya, April 2014 (poster presentation)

5.      Sapmaz ŞY, Ergin D, Celasin NŞ, Öztürk M, Erkuran HÖ, Karaarslan D, Köroğlu E, Aydemir Ö. “Validity and reliability of the Turkish version of DSM-5 agoraphobia severity scale-child form”. 8th International Congress on Psychopharmacology & 4th International Symposium on Child and Adolescent Psychopharmacology, Antalya, April 2016 (poster presentation)

6.      Sapmaz ŞY, Erkuran HÖ, Ergin D, Celasin NŞ, Karaarslan D, Öztürk M, Köroğlu E, Aydemir Ö. “Validity and reliability of the Turkish version of DSM-5 acute stress symptom severity scale-child form”. 8th International Congress on Psychopharmacology & 4th International Symposium on Child and Adolescent Psychopharmacology, Antalya, April 2016 (poster presentation)

7.      Sapmaz ŞY, Yalın N, Erkuran HÖ, Öztekin S, Tanrıverdi BU, Köroğlu E, Aydemir Ö. “Validity and reliability of the Turkish version of DSM-5 Depression Severity Scale-Child Form”. 8th International Congress on Psychopharmacology & 4th International Symposium on Child and Adolescent Psychopharmacology, Antalya, April 2016 (poster presentation)

8.      Sapmaz ŞY, Ergin D, Celasin NŞ, Karaarslan D, Öztürk M, Erkuran HÖ, Köroğlu E, Aydemir Ö. “Validity and reliability of the Turkish version of DSM-5 social anxiety disorder severity scale-child form”. 8th International Congress on Psychopharmacology & 4th International Symposium on Child and Adolescent Psychopharmacology, Antalya, April 2016 (poster presentation)

9.      Sapmaz ŞY, Erkuran HÖ, Ergin D, Celasin NŞ, Karaarslan D, Öztürk M, Köroğlu E, Aydemir Ö. “Validity and reliability of the Turkish version of DSM-5 specific phobia severity scale-child form”. 8th International Congress on Psychopharmacology & 4th International Symposium on Child and Adolescent Psychopharmacology, Antalya, April 2016 (poster presentation)

10.   Sapmaz ŞY, Ergin D, Erkuran HÖ, Celasin NŞ, Karaarslan D, Öztürk M, Köroğlu E, Aydemir Ö. “Validity and reliability of the Turkish version of DSM-5 generalized anxiety disorder severity scale child form”. 8th International Congress on Psychopharmacology & 4th International Symposium on Child and Adolescent Psychopharmacology, Antalya, April 2016 (poster presentation)

11.  Sapmaz ŞY, Ergin D, Celasin NŞ, Erkuran HÖ, Karaarslan D, Öztekin S, Tanrıverdi BU, Köroğlu E, Aydemir Ö. “Turkish validity and reliability of DSM-5 dissociative symptoms severity scale-child form”. 8th International Congress on Psychopharmacology & 4th International Symposium on Child and Adolescent Psychopharmacology, Antalya, April 2016 (poster presentation)

12.  Sapmaz ŞY, Ergin D, Celasin NŞ, Öztürk M, Erkuran HÖ, Karaarslan D, Köroğlu E, Aydemir Ö. “Validity and reliability of the Turkish version of DSM-5 posttraumatic stress symptom severity scale-child form”. 8th International Congress on Psychopharmacology & 4th International Symposium on Child and Adolescent Psychopharmacology, Antalya, April 2016 (poster presentation)

13.  Sapmaz ŞY, Erkuran HÖ, Ergin D, Celasin NŞ, Karaarslan D, Öztürk M, Köroğlu E, Aydemir Ö. “Validity and reliability of the Turkish version of DSM-5 acute stress symptom severity scale-child form”. 8th International Congress on Psychopharmacology & 4th International Symposium on Child and Adolescent Psychopharmacology, Antalya, April 2016 (poster presentation)

14.  Sapmaz ŞY, Kavurma C, Erkuran HÖ, Öztürk M, Tanrıverdi BU, Köroğlu E, Aydemir Ö. “Validity and reliability of DSM-5 Level 1 Cross-cutting Symptom Scale Turkish version (Child Form for 11−17 years and Parent Form for 6−17 years)”. 8th International Congress on Psychopharmacology & 4th International Symposium on Child and Adolescent Psychopharmacology, Antalya, April 2016 (poster presentation)

15.  Erkuran HÖ, Sapmaz ŞY, Herdem A, Öztürk M, Bilaç Ö, Önen Ö, Tanrıverdi BU, Köroğlu E, Aydemir Ö. “DSM-5 level 2 sleep disorders scale Turkish validity and reliability study”. 8th International Congress on Psychopharmacology & 4th International Symposium on Child and Adolescent Psychopharmacology, Antalya, April 2016 (poster presentation)

16.  Sapmaz ŞY, Demirgören BS, Öztürk M, Bilaç Ö, Erkuran HÖ, Köroğlu E, Aydemir Ö. “The Reliability and Validity of the Turkish Version of DSM-5 Level 2 Inattention Scale (Parent Form for 6-17 Years)”. 9th International Congress on Psychopharmacology & 5th International Symposium on Child and Adolescent Psychopharmacology, Antalya, April 2017 (oral presentation)

17.  Önen Ö, Kutlu A, Erkuran HÖ. “Dıagnosıng An 11-Year Old Gırl Wıth Narcolepsy In A Chıld Psychıatry Unıt: A Case Presentatıon”. 9th International Congress on Psychopharmacology & 5th International Symposium on Child and Adolescent Psychopharmacology, Antalya, April 2017 (poster presentation)

18.  Yaylacı F, Erkuran HÖ, Eyüboğlu M. “Early-term Aripiprazole Augmentation and Clinical Efficacy: A Case Series of Six Adolescents”. 9th International Congress on Psychopharmacology & 5th International Symposium on Child and Adolescent Psychopharmacology, Antalya, April 2017 (poster presentation)

19.  Erkuran HÖ, Aşık EA, Sapmaz ŞY. “Dıagnostıc And Treatment Process In A 12-Year Old Adolescent Wıth Kleıne-Levın Syndrome: A Case Presentatıon”. 9th International Congress on Psychopharmacology & 5th International Symposium on Child and Adolescent Psychopharmacology, Antalya, April 2017 (poster presentation)

20.  Yaylacı F, Erkuran HÖ. “Acute Dystonic Reaction Induced by Low-Dose Aripiprazole In an Adolescent Case”. 9th International Congress on Psychopharmacology & 5th International Symposium on Child and Adolescent Psychopharmacology, Antalya, April 2017 (poster presentation)

21.  Sapmaz ŞY, Erkuran HÖ, Ergin D, Celasin NŞ, Öztürk M, Karaarslan D, Köroğlu E, Aydemir Ö. “Valıdıty And Relıabılıty Of The Turkısh Versıon Of Dsm-5 Separatıon Anxıety Dısorder Severıty Scale- Chıld Form”. 17th International Congress of European Society for Child and Adolescent Psychiatry (ESCAP), Geneva, July 2017 (poster presentation)

22.  Sapmaz ŞY, Demirgören BS, Öztürk M, Bilaç Ö, Erkuran HÖ, Köroğlu E, Aydemir Ö. “Validity and Reliability of the Turkish Version of DSM-5 Level 2 Inattention Scale (Parent Form for 6-17 Years)”. 17th International Congress of European Society for Child and Adolescent Psychiatry (ESCAP), Geneva, July 2017 (poster presentation)

23.  Kutlu A, Erkuran HÖ. “Preschool Bipolar Disorder: Three Cases and Their Follow- Up”. 17th International Congress of European Society for Child and Adolescent Psychiatry (ESCAP), Geneva, July 2017 (poster presentation)

24.  Küçük Ö, Yaylacı F, Erkuran HÖ. “Oropharyngeal dysphagia induced by zuclopenthixol acetate”. 10th International Congress on Psychopharmacology & 6th International Symposium on Child and Adolescent Psychopharmacology, Antalya, April 2018 (poster presentation)

25.  Yaylacı F, Küçük Ö, Erkuran HÖ. “L-carnitine use as a triggering factor for the onset of Kleine- Levin syndrome: a case presentation”. 10th International Congress on Psychopharmacology & 6th International Symposium on Child and Adolescent Psychopharmacology, April 2018 (poster presentation)

26.   Erkuran HÖ, Küçük Ö, Yaylacı F, Şahbudak B. “OCD in the context of separation and Individualization: a case presentation”. 23rd World Congress of the International Association for Child and Adolescent Psychiatry and Allied Professions (IACAPAP), Prague, July 2018 (poster presentation)

27.  Erkuran HÖ, Yaylacı F, Küçük Ö, Şahbudak B. “Terrified of menstruating: a case of anorexia”. 23rd World Congress of the International Association for Child and Adolescent Psychiatry and Allied Professions (IACAPAP), Prague, July 2018 (poster presentation)

28.  Erkuran HÖ, Binici NC, Önen Ö, Kutlu A, Balım A, Çakaloz B. “Evaluation of disability reports in a children’s hospital: Data of a 1-year retrospective chart review”. 23rd World Congress of the International Association for Child and Adolescent Psychiatry and Allied Professions (IACAPAP), Prague, July 2018 (oral presentation- research symposium)

8.      National Presentations and Abstracts:

1.      Önen Ö, Özek H, İşcanlı L, Gencer Ö. “Cinsel istismara uğrayan ergenlerde bireysel, ailesel ve istismara ait özelliklerin tanımlanarak istismara uğrama ve psikiyatrik bozukluk oluşumu üzerine etkilerinin araştırılması: Kontrollü bir çalışma”. 19. Ulusal Çocuk ve Ergen Ruh Sağlığı ve Hastalıkları Kongresi, Antakya, Nisan 2009 (poster presentation)

2.      Özek H, Akay AP, Alşen S, Kurul SH, Emiroğlu FN, Ellidokuz H. “Epilepsi Tanısı olan Çocukların Annelerinin Tepkileri: Anksiyete, Depresyon, Tutum ve Aile İşlevleri”. 20. Ulusal Çocuk ve Ergen Ruh Sağlığı ve Hastalıkları Kongresi, Bodrum, Nisan 2010 ( oral presentation)

3.      Dursun OB, Güvenir T, Aras Ş, Ergin C, Mutlu C, Özbek A, Özek H, Alşen S, İşcanlı L, Karaman Bİ, Goodman R. “Yeni bir tanılama aracı; Gelişim ve Ruhsal Sağlık Değerlendirmesi tanı paketinin Türkçe geçerlik ve güvenirlik çalışması. 21. Ulusal Çocuk ve Ergen Ruh Sağlığı ve Hastalıkları Kongresi,Antalya, Nisan 2011 (poster presentation)

4.      Akıncı G, Öztura I, Kurul SH, Akdoğan O, Akay AP, Özek H. “Dikkat Eksikliğive Hiperaktivite Bozukluğu olan Çocuklarda Uyku Bozukluklarının Değerlendirilmesi”. 13. Ulusal Çocuk Nörolojisi Kongresi, Kapadokya, Mayıs 2011 (poster presentation)

5.      Akay AP, Kaya GÇ, Baykara B, Demir Y, Eren MŞ, Erkuran HÖ, Emiroğlu N, Ertay T, Öztürk Y, Miral S. 24. Ulusal Nükleer Tıp Kongresi, Antalya, Nisan 2012 (poster bildiri)

6.      Erkuran HÖ. “Internet Bağımlılığı Nörobiyolojisi ve Eşlik Eden Psikiyatrik Durumlar”. 9. Ulusal Alkol ve Madde Bağımlılığı Kongresi, Edirne, Aralık 2015 (oral presentation)

7.      Sapmaz ŞY, Erkuran HÖ, Yalın N, Önen Ö, Öztekin S, Kavurma C, Köroğlu E, Aydemir Ö. “DSM-5 Düzey 2 Öfke Ölçeği Türkçe Formu’nun Güvenirliği ve Geçerliği (11-17 yaş çocuk formu ve 6-17 yaş ebeveyn formu)”. 26. Çocuk ve Ergen Ruh Sağlığı ve Hastalıkları Kongresi, İzmir, Nisan 2016 (oral presentation)

8.      Sapmaz ŞY, Ergin D, Erkuran HÖ, Celasin NŞ,Karaarslan D, Öztürk M, Köroğlu E, Aydemir Ö. “DSM-V Panik Bozukluk Şiddeti Ölçeği Çocuk Formu’nun Türkçe Güvenirlik ve Geçerliği”. 26. Çocuk ve Ergen Ruh Sağlığı ve Hastalıkları Kongresi, İzmir, Nisan 2016 (oral presentation)

9.      Sapmaz ŞY, Erkuran HÖ, Karaaslan D, Öztürk M, Ülker GY, Demirgören BS, Köroğlu E, Aydemir Ö. “DSM-5 Düzey 2 Anksiyete Ölçeği Türkçe Formunun Güvenilirliği ve Geçerliliği (11-17 yaş çocuk ve 6-17 yaş ebeveyn formları)”. 26. Çocuk ve Ergen Ruh Sağlığı ve Hastalıkları Kongresi, İzmir, Nisan 2016 (poster presentation)

10.  Sapmaz ŞY, Ergin D, Erkuran HÖ, Celasin NŞ, Karaarslan D, Öztürk M, Köroğlu E, Aydemir Ö. “DSM-5 Panik Bozukluk Şiddet Ölçeği Çocuk Formu'nun Türkçe Güvenilirliği ve Geçerliliği”. 26. Çocuk ve Ergen Ruh Sağlığı ve Hastalıkları Kongresi, İzmir, Nisan 2016 (poster presentation)

11.  Sapmaz ŞY, Erkuran HÖ, Öztekin S, Tanrıverdi BU, Kavurma C, Köroğlu E, Aydemir Ö. “DSM-5 Düzey 2 Yineleyici Düşünceler ve Davranışlar Ölçeği Çocuk Formunun Türkçe Güvenilirliği ve Geçerliliği”. 26. Çocuk ve Ergen Ruh Sağlığı ve Hastalıkları Kongresi, İzmir, Nisan 2016 (poster presentation)

12.  Sapmaz ŞY, Erkuran HÖ, Kavurma C, Öztürk M, Tanrıverdi BU, Köroğlu E, Aydemir Ö. “DSM-V Düzey 1 Kesitsel Belirti Tarama Ölçeği Türkçe Formu’nun Geçerliği ve Güvenirliği (11-17 Yaş Çocuk Formu ve 6-17 yaş Ebeveyn Formu)”. 15. Ulusal Aile Hekimliği Kongresi, Ankara, Ekim 2016 (oral presentation)

13.  Önen Ö, Kundak S, Erkuran HÖ, Kutlu A, Çakaloz B. “Vitiligo Hastalığı olan Çocuklar ve Ebeveynlerinin Yaşam Kalitesi, Depresyon ve Kaygı Düzeyleri”. 5. Ulusal Sağlıkta Yaşam Kalitesi Kongresi, İzmir, Kasım 2016 (oral presentation)

14.  Sapmaz ŞY, Erkuran HÖ, Ergin D, Celasin NŞ, Öztürk M, Karaarslan D, Köroğlu E, Aydemir Ö. “DSM-5 Ayrılık Anksiyetesi Bozukluğu Şiddet Ölçeği Çocuk Formu’nun (11-17 yaş) Türkçe Güvenirlik ve Geçerliği”. 21. Ergen Günleri, Denizli, Aralık 2016 (oral presentation)

15.  Önen Ö, Kutlu A, Erkuran HÖ. “Long QT Sendromu Tanılı Ergen Bipolar Olguda Tedavi: Bir Olgu Sunumu”. 21. Ergen Günleri, Denizli, Aralık 2016 (oral presentation)

16.  Erkuran HÖ. “Bebek ve Küçük Çocuklarda Beslenme Bozuklukları”. Dr Behçet Uz Kış Okulu, İzmir, Aralık 2016 (speaker)

17.  Erkuran HÖ, Sapmaz ŞY, Ünlü GE, Çakaloz B, Kutlu A, Önen Ö. “Çocuk ve Ergenlerde Atipik Antipsikotik Kullanımı, Metabolik Sendrom ve İlişkili Etmenler”. 3. Selahattin Şenol Bahar Okulu, Bodrum, Mart 2017 (oral presentation)

18.  Erkuran HÖ. “Otistik Spektrum Bozukluklarında Davranış Sorunları ve Baş Etme Yöntemleri”. İzmir Halk Sağlığı Müdürlüğü, Mart 2017 (speaker)

19.  Akıncı G, Eraslan C, Demir M, Erkuran HÖ, Gürbüz G, Özyılmaz B, Edizer S, Yılmaz S, Ünalp A. “Korpus kallozum anormalliklerinde nöroradyolojik sınıflamanın klinik, nöropsikiatrik, ve genetik özellikler ile ilişkisi”. 19. Ulusal Çocuk Nöroloji Kongresi, Antalya, Nisan 2017 (poster presentation)

20.  Akay AP, Güney SA, Erkuran HÖ, Gönül AS, Baykara B, Emiroğlu Nİ, Eren MŞ, Keskin D, Erkaya T, Kaya GÇ, Demir Y, Miral S, Durak H. “An Imaging Discontinuation Study of Adolescents with ADHD using OROS- Methylphenidate: Assessing with [Tc-99m] TRODAT-1 SPECT”. 27th Turkish Child and Adolescent Psychiatry Congress, Çeşme, Mayıs 2017 (oral presentation)

21.  Akay AP, Yazıcıoğlu ÇE, Erkuran HÖ, Güney SA, Gönül AS, Baykara B, Emiroğlu N, Demir Y, Eren MŞ, Kızıldağ S, Gökçelli DK, Ertay T, Özsoylu D, Miral S, Durak H, Kaya GÇ. “A Genetic Imaging Study of Adolescents with Attention-deficit/Hyperavtivity Disorder using OROS-Methylphenidate: Assessing the Dopamine Transporter Gene with [Tc-99m] TRODAT-1 SPECT”. 27th Turkish Child and Adolescent Psychiatry Congress, Çeşme, Mayıs 2017 (poster presentation)

22.  Erkuran HÖ. “Çocuk Ruh Sağlığı Sınır İhlali Komisyonu”. 27. Ulusal Çocuk ve Ergen Ruh Sağlığı ve Hastalıkları Kongresi, Çeşme, Mayıs 2017 (speaker)

23.  Erkuran HÖ. “Anksiyete Bozuklukları, Travma ve Stresle İlişkili Bozukluklar ve İnflamasyon”. 27. Ulusal Çocuk ve Ergen Ruh Sağlığı ve Hastalıkları Kongresi, Çeşme, Mayıs 2017 (oral presentation)

24.  Sapmaz ŞY, Erkuran HÖ, Tanrıverdi BU, Öztürk M, Köroğlu E, Aydemir Ö. “DSM-5 Kişilik Envanteri Çocuk Formunun Türkçe Güvenilirliği ve Geçerliliği”. 22. Ulusal Ergen Günleri, İstanbul, Aralık 2017 (poster presentation)

25.  Erkuran HÖ. “Çocuk Psikiyatrisi ve Diyet”. 28. Ulusal Çocuk ve Ergen Ruh Sağlığı ve Hastalıkları Kongresi, İstanbul, Mayıs 2018 (speaker)

26.  Erkuran HÖ. “Dikkat Eksikliği ve Hiperaktivite Bozukluğu’nda Neurofeedback ve Alternatif Tedavilerin Yeri”. 54. Ulusal Psikiyatri Kongresi, İzmir, Ekim 2018 (speaker)

27.  Yaylacı F, Küçük Ö, Erkuran HÖ, Şahbudak B. “Effects of Shadow Teacher Intervention on Emotional and Behavioral Characteristics, Bullying and the Overall Life Quality of the Family of a Case Diagnosed with Autistic Spectrum Disorder who was Bullied at School”. 28. Çocuk ve Ergen Ruh Sağlığı ve Hastalıkları Kongresi, İstanbul, Mayıs 2018 (oral presentation)

9.      Internationally/Nationally Published Books/Book Chapters

1.      Sapmaz ŞY, Erkuran HÖ (2016). Çocuklarda ve Ergenlerde Uyku Bozuklukları. Erhan Akıncı, Fatma Özlem Orhan ve Mehmet Murat Demet (Ed.), Uyku Bozuklukları Tanı ve Tedavi Kitabı (s. 305-315) içinde. Yer: Türk Psikiyatri Derneği, Ankara.

2.      Erkuran HÖ, Akay AP (2017). Karın Ağrısı/Bedensel Belirti Bozukluğu. Salih Kavukçu (Ed.), Olgu Örnekleri ile Tanıdan Tedaviye Çocuk Hastalıkları (1.bs, ISBN: 978-605-9415-29-3) içinde. Yakın Doğu Üniversitesi Yayınevi.

10.  Medical dissertation thesis: Evaluation of Plasma Dopamine and Noradrenaline Levels in Children Diagnosed with Attention Deficit Hyperactivity Disorder (2012, Dokuz Eylul University, School of Medicine, Child and Adolescent Psychiatry Department, Izmir).

Supervisor: Prof. Dr. Aynur AKAY

11.  Citations: 75 (updated in February 2019)

1.      Maternal reactions to a child with epilepsy: depression, anxiety, parental attitudes and family functions

                                                              i.      39 citations

2.      Sleep structure in children with Attention- Deficit/Hyperactivity Disorder

                                                              i.      16 citations

3.      Evaluation of serum brain-derived neurotrophic factor levels in children with Attention Deficit Hyperactivity Disorder: preliminary Data

                                                              i.      6 citations

4.      A new Diagnostic Approach for Turkish speaking populations DAWBA Turkish Version

                                                              i.      4 citations

5.      Topiramate in the Adjunctive Treatment of Tourette Syndrome: A Case Report

                                                              i.      2 citations

6.      Cinsel istismara uğrayan ergen olgularda bireysel, ailesel ve istismara ait özelliklerin tanımlanması ve bu özellikler ile birlikte başa çıkma biçimleri, aile işlevleri ve anne- baba tutumlarının ve olgu olmaya etkisinin belirlenmesi

                                                              i.      2 citations

7.      Allele frequencies of dopamine D4 receptor gene (DRD4) and Catechol-O-methyltransferase (COMT) Val158Met polymorphism are associated with methylphenidate response in adolescents with Attention Deficit/Hyperactivity Disorder: a case/control preliminary study

                                                              i.      1 citation

8.      Serum brain-derived neurotrophic factor levels in treatment- naive boys with Attention Deficit Hyperactivity Disorder treated with methylphenidate: an 8-week, observational pretest-posttest study

                                                              i.      1 citation

9.      Validity and Reliability of the Turkish Version for DSM-5 Level 2 Anger Scale (Child Form for Children Aged 11-17 Years and Parent Form for Children Aged 6-17 Years)

                                                              i.      1 citation

10.  Preschool bipolar disorder: three cases and their follow-up

                                                              i.      1 citation

11.  Suicide attempt with high dose long acting methylphenidate ingestion: a case presentation

                                                              i.      1 citation

12.  Plasma Norepinephrine and Dopamine Levels in Prepubertal Male Children with Attention Deficit- Hyperactivity Disorder do not change with 8 weeks of methylphenidate treatment

                                                              i.      1 citation

12.  Memberships to Professional association and foundations:

1.      Turkish Medical Association

2.      Psychiatric Association of Turkey

3.      Turkish Association for Child and Adolescent Psychiatry

4.      Turkish Association of Cognitive and Behavioral Therapies

13.  Awards:

Prof. Dr. Atilla Turgay Poster Presentation Award, 1st Place.  27th Turkish Child and Adolescent Psychiatry Congress, May 2017, Çeşme/Turkey.